NUVL Q3 2024 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$76M

Net Income

-$84M

EPS (Diluted)

$-1.28

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$68M

Stockholders' Equity

$1.1B

Cash & Equivalents

$369M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$76M	-$39M	-96.8%
Net Income	-$84M	-$34M	-150.7%